Literature DB >> 1383411

Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses.

K Matsuo1, Y Nishino, T Kimura, R Yamaguchi, A Yamazaki, T Mikami, K Ikuta.   

Abstract

Linear B cell epitopes were mapped on the major core protein p24 of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus (SIVAGM) and feline immunodeficiency virus (FIV) using a fusion protein-based method and murine monoclonal antibodies reactive against the p24 antigens expressed on the surface of HIV-1- and FIV-infected cells. The results suggest that the sites identified here are encoded at similar positions in the three virus genomes and consist of highly conserved epitopes, which could exhibit immunodominance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383411     DOI: 10.1099/0022-1317-73-9-2445

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Advances in FIV vaccine technology.

Authors:  Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2008-01-20       Impact factor: 2.046

2.  Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.

Authors:  Masaru Kanekiyo; Kazuhiro Matsuo; Makiko Hamatake; Takaichi Hamano; Takeaki Ohsu; Sohkichi Matsumoto; Takeshi Yamada; Shudo Yamazaki; Atsuhiko Hasegawa; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.

Authors:  S M Lonning; W Zhang; T C McGuire
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 4.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.

Authors:  Yasuyuki Izumi; Yasushi Ami; Kazuhiro Matsuo; Kenji Someya; Tetsutaro Sata; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.

Authors:  Priya Chikhlikar; Luciana Barros de Arruda; Milton Maciel; Peter Silvera; Mark G Lewis; J Thomas August; Ernesto T A Marques
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

Review 8.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03

9.  Prime-boost immunization of codon optimized HIV-1 CRF01_AE Gag in BCG with recombinant vaccinia virus elicits MHC class I and II immune responses in mice.

Authors:  Duanthanorm Promkhatkaew; Nadthanan Pinyosukhee; Wilai Thongdeejaroen; Jantima Teeka; Preeda Wutthinantiwong; Preecha Leangaramgul; Pathom Sawanpanyalert; Paijit Warachit
Journal:  Immunol Invest       Date:  2009       Impact factor: 3.044

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.